Coronavirus Briefing Newsletter – Times of India

  • India on Friday reported 5,383 Covid cases and 20 deaths. The cumulative amount is 4,45,58,425 (45,281 active cases) and 5,28,449 deaths
  • All around the world: More than 614 million cases and over 6.53 million deaths.
  • Vaccination in India: More than 2.17 billion doses. Worldwide: More than 12.25 billion doses.
Blood test can identify the risk of serious Covid disease
Blood test can identify the risk of serious Covid disease
  • One genomic testing has been developed by a US company that claims to predict a patient’s risk of severe Covid-19 illness. This information can help doctors identify high-risk patients with poor outcomes and quickly initiate appropriate treatment to reduce the chance of hospitalization.
  • The biotech company AMPEL BioSolutions claims that the test, called CovGENE, was validated by a longitudinal study conducted in conjunction with a team from the University of Virginia Medical Center (UVA).
  • How it works: CovGENE analyzes the genes expressed in a person’s blood to determine if they may be experiencing a severe illness with a high risk of death.
  • “Our study used genetic analysis to identify an immune cell marker that, distinct from other respiratory diseases, is associated with worse outcomes,” said lead researcher Alexandra Kadl.
  • Researchers published Their findings are published in the journal Frontiers in Immunology.
  • Effective: The trial demonstrated more than 90% accuracy in predicting outcomes for more than two dozen ICU patients in UVA and 100 patients from public data generated at Duke and Harvard.
  • What is next: Based on the promising results of the research, the developer of CovGENE is now looking to partner with a diagnostic testing company or pharmaceutical company to bring the approach to market as a blood test based on simple PCR.
The link between type 1 diabetes and Covid
The link between type 1 diabetes and Covid
  • Testing positive for SARS-CoV-2, the virus that causes Covid-19, is associated with an increased risk of new-onset Type 1 diabetes in children and adolescents, according to a new study. new research led by Hanne Lovdal Gulseth and Dr. Germany Tapia of the Norwegian Institute of Public Health, Oslo.
  • It has long been suspected that Type 1 diabetes, which is often diagnosed in young people and is associated with the pancreas’ failure to produce insulin, is the result of an overactive immune response, can be caused by viral infections, including respiratory tract. virus.
  • For the study, the researchers used a national health registry to examine diagnoses of new-onset Type 1 diabetes made in all young adults under 18 years of age in Norway (more than 1 year old). .2 million people) over the course of 2 years, beginning March 1, 2020, comparing those who had Covid -19 with those who did not.
  • During the two-year study period, a total of 4,24,354 children tested positive for SARS-CoV-2 infection and 990 new-onset cases of type 1 diabetes were diagnosed out of 1.2 million. children and adolescents participated in the study.
  • After adjusting for age, sex, country of origin, geographic region, and socioeconomic factors, the analyzes showed that young people infected with Covid were at increased risk of developing type 1 diabetes. after 30 days or so about 60% more than those who did not have a registered infection or who tested negative for the virus.

Follow the news that matters to you in real time.
Join 3 crore news enthusiasts.

Written by: Rakesh Rai, Sushmita Choudhury, Jayanta Kalita, Prabhash K Dutta
Research: Rajesh Sharma

Source link


News 7D: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button